Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-23

Clinical Trial Update: Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a polyherbal coded formulation Obesecure for leptin regulation and obesity management has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Obesecure

Snippet

Sponsor: Hafiz Muhammad Asif | Conditions: Leptin Deficiency, Obesity | Phase 2 | Status: COMPLETED